Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme 2016


Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme is an annual national research project grants scheme which funds cancer research in identified priority areas to help reduce the impact of cancer in the community and improve outcomes for people affected by cancer.

Through its partnership approach, the PdCCRS brings together funders of cancer research to
co-ordinate funding of priority-driven cancer research at the national level and maximise cancer research investment across Australia. The Scheme is also designed to foster collaboration between cancer researchers to build Australia’s cancer research capacity, and encourage   consumer participation in cancer research, from design to implementation

The scheme aims to:
  • fund research in tumour areas that place a high burden of disease on the Australian community;
  • fund cancer research projects that directly relate to the identified priorities of Cancer Australia and/or its Funding Partners; and
  • fund research that can directly improve cancer outcomes by influencing clinical practice, policy and/or care.


IMPORTANT PdCCRS DATES INFORMATION
  • PdCCRS application documents will be available on the Cancer Australia website from 21 December 2015;
  • Applications to the PdCCRS  can be submitted through the NHMRC’s Research Grants Management System (RGMS) from 13 January 2016;
  • Applicants intending to apply to the PdCCRS Young Investigator categories MUST complete the New Investigator online eligibility form on the NHMRC website by 27 January 2016;
  • Minimum application data must be entered into RGMS by 17 February 2016;
  • Applications to the 2016 round of the PdcCRS close in line with the NHMRC Project Grants round at 5pm AET 16 March 2016.


In 2016, Cancer Australia and its partners:
  • Australasian Sarcoma Study Group
  • Cancer Council Australia
  • Cancer Council NSW
  • Cure Cancer Australia
  • National Breast Cancer Foundation
  • The Kids’ Cancer Project
will offer funding for project grants in identified priority areas.


The following funding categories will be offered through the Priority-driven Collaborative Cancer Research Scheme in 2016.

Funding Category A: Project grants of up to three years duration, with funding available up to $600,000 (GST-exclusive), with a maximum in any one year of $200,000 (GST-exclusive) will be offered by Cancer Australia, Australasian Sarcoma Study Group, Cancer Council Australia, Cancer Council NSW, National Breast Cancer Foundation and The Kids’ Cancer Project. All project grant applications ranging from 1 to 3 years within a budget ranging from $10,000 to $200,000 per annum will be considered by Cancer Australia and these funding partners.

These research projects must be:

  • Priority-driven (relate specifically to a research priority area specified by Cancer Australia and/or a Funding Category A funding partner).
  • Outcome/impact focused (projects will improve outcomes in cancer control and/or impact on populations with poorer outcomes within the community).
  • Translatable (approaches and methodologies will be provided to translate research findings to impact on clinical practice, policy and/ or further research in order to impact on cancer control in Australia).
  • Collaborative (projects are cross-disciplinary, national, multi-state, multi-institutional and/or key disciplines are part of the grant application).
  • Engage consumers (consumers are involved in the design and ongoing conduct of the research project).

Funding Category B: Project grants of one year duration and up to $100,000 (GST-exclusive) will be offered by Cancer Australia and Cure Cancer Australia,  to support project grants by post-doctoral researchers with 1-3 years post-doctoral experience, or 1-3 years post MBBS qualification, undertaking a one year research project into malignant disease.

Funding Category C: Project grants of up to 2 years duration and up to $200,000 (GST-exclusive), with a maximum in any one year of $100,000, will be offered by Cancer Australia and Cure Cancer Australia to support project grants by post-doctoral researchers with 4-7 years post-doctoral experience or 4-7 years post MBBS qualification, undertaking a 1-2 years research project into malignant disease.

Funding Categories B and C cannot be used to provide a salary or other support for a young investigator as part of a larger PdCCRS project grant application.

These research projects must demonstrate:
  • Alignment with a research priority area (relate specifically to a research priority area specified by Cancer Australia and/ or Cure Cancer Australia Foundation.
  • Track record of the applicant in regard to opportunity (list of all publications and patents and a description of the applicants role in the publications and patents, summary of research experience, other relevant experience, and academic qualifications and awards).  
  • Career development (career development objectives, and research environment in which the research will be undertaken).
  • Relevance of project to cancer control.
  • Consumer involvement (involvement in identifying relevance, study design, or consumer engagement in the development of this project).

For further information:
  • Visit the Cancer Australia website or
  • Contact Dr Ameera Yousiph, Senior Project Officer Research, Cancer Australia, Email: grants@canceraustralia.gov.au    
 Find a Sarcoma Specialist
 Ask a Question
Support Sarcoma Research